Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Echinocandins: are they all the same?

Mukherjee PK, Sheehan D, Puzniak L, Schlamm H, Ghannoum MA.

J Chemother. 2011 Dec;23(6):319-25. Review.

PMID:
22233814
2.

Echinocandins: The Expanding Antifungal Armamentarium.

Aguilar-Zapata D, Petraitiene R, Petraitis V.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S604-11. doi: 10.1093/cid/civ814. Review.

PMID:
26567277
3.

A clinical review of echinocandins in pediatric patients.

VandenBussche HL, Van Loo DA.

Ann Pharmacother. 2010 Jan;44(1):166-77. doi: 10.1345/aph.1M139. Epub 2009 Dec 15. Review.

PMID:
20009006
4.

Echinocandins: production and applications.

Emri T, Majoros L, Tóth V, Pócsi I.

Appl Microbiol Biotechnol. 2013 Apr;97(8):3267-84. doi: 10.1007/s00253-013-4761-9. Epub 2013 Mar 6. Review.

PMID:
23463246
5.

Echinocandins: the newest class of antifungals.

Sucher AJ, Chahine EB, Balcer HE.

Ann Pharmacother. 2009 Oct;43(10):1647-57. doi: 10.1345/aph.1M237. Epub 2009 Sep 1. Review.

PMID:
19724014
6.

The echinocandins.

Cappelletty D, Eiselstein-McKitrick K.

Pharmacotherapy. 2007 Mar;27(3):369-88. Review.

PMID:
17316149
7.

Anidulafungin, a new echinocandin: in vitro activity.

Morace G, Borghi E, Iatta R, Montagna MT.

Drugs. 2009;69 Suppl 1:91-4. doi: 10.2165/11315560-000000000-00000. Review.

PMID:
19877740
8.

[Echinocandins in children].

Leverger G, Le Guyader N.

Arch Pediatr. 2011 May;18 Suppl 1:S33-41. doi: 10.1016/S0929-693X(11)70938-1. French.

PMID:
21596285
9.

Recent approaches to antifungal therapy for invasive mycoses.

Mathew BP, Nath M.

ChemMedChem. 2009 Mar;4(3):310-23. doi: 10.1002/cmdc.200800353. Review.

PMID:
19170067
10.

Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.

Katragkou A, Roilides E, Walsh TJ.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S622-9. doi: 10.1093/cid/civ746. Review.

PMID:
26567280
11.

Micafungin: a sulfated echinocandin.

Hashimoto S.

J Antibiot (Tokyo). 2009 Jan;62(1):27-35. doi: 10.1038/ja.2008.3. Epub 2009 Jan 9.

PMID:
19132058
12.

Echinocandins--new antifungal agents.

Stan CD, Tuchiluş C, Stan CI.

Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):528-36.

PMID:
25076727
13.

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.

Fera MT, La Camera E, De Sarro A.

Expert Rev Anti Infect Ther. 2009 Oct;7(8):981-98. doi: 10.1586/eri.09.67. Review.

PMID:
19803707
14.

Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.

Lee SC, Lee CW, Shih HJ, Huang SH, Chiou MJ, See LC.

J Microbiol Immunol Infect. 2014 Jun;47(3):245-53. doi: 10.1016/j.jmii.2013.09.006. Epub 2013 Nov 15.

15.

Role of micafungin in the antifungal armamentarium.

Ikeda F, Tanaka S, Ohki H, Matsumoto S, Maki K, Katashima M, Barrett D, Aoki Y.

Curr Med Chem. 2007;14(11):1263-75. Review.

PMID:
17504145
16.

[Micafungin: experimental therapy of fungal infections in animal models].

Javier Pastor F, Guarro J.

Rev Iberoam Micol. 2009 Mar 31;26(1):42-8. doi: 10.1016/S1130-1406(09)70007-5. Epub 2009 May 7. Review. Spanish.

17.

Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.

Kuti EL, Kuti JL.

Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1287-300. doi: 10.1517/17425255.2010.518143. Review.

PMID:
20822479
18.

Echinocandins in the management of invasive fungal infections, part 1.

Morris MI, Villmann M.

Am J Health Syst Pharm. 2006 Sep 15;63(18):1693-703. Review.

PMID:
16960253
19.

Echinocandins in children.

Hoffman JA, Walsh TJ.

Pediatr Infect Dis J. 2011 Jun;30(6):508-9. doi: 10.1097/INF.0b013e31821b95e2. Review. No abstract available.

PMID:
21587028

Supplemental Content

Support Center